Real-world effectiveness of clozapine for intellectual disability: Results from a mirror-image and a reverse-mirror-image study.
Christopher RohdeRikke HilkerDan J SiskindJimmi NielsenPublished in: Journal of psychopharmacology (Oxford, England) (2018)
This nationwide study, which is the largest to date, suggests that treatment with clozapine is associated with a reduction in psychiatric admissions and inpatient days in patients with intellectual disability. Further studies evaluating the effects of clozapine in patients with intellectual disability are warranted.